VEGF in patients with non-small cell lung cancer during combination chemotherapy of carboplatin and paclitaxel.

Masato Shingyoji(Chiba Cancer Center), Hideki Kimura, Meiji Itakura(Chiba Cancer Center), Toshihiko Iizasa(Chiba Cancer Center), Hiroki Nishimura(The Cancer Institute Hospital), Aki Ishikawa(Chiba Cancer Center), Soichiro Ando, Takahiro Nakajima(University Health Network)

PubMed

July 1, 2009

Cited by 7

Related Papers

Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma

|Lung Cancer|2013|261

Regulation by Chemokines of Circulating Dendritic Cell Precursors, and the Formation of Portal Tract–Associated Lymphoid Tissue, in a Granulomatous Liver Disease

|The Journal of Experimental Medicine|2000|198

Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations

|International Journal of Clinical Oncology|2014|167

Comparison of 21‐gauge and 22‐gauge aspiration needle during endobronchial ultrasound‐guided transbronchial needle aspiration

|Respirology|2010|141

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties

|Nature Communications|2020|107